| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antihypertensive therapy to maximally reduce coronary risk
|
Kaplan, Norman M
|
|
1993
|
125 |
5P2 |
p. 1487-1493
7 p.
|
artikel
|
| 2 |
Cardiac effects of trandolapril in hypertension
|
Guller, Barbara
|
|
1993
|
125 |
5P2 |
p. 1536-1541
6 p.
|
artikel
|
| 3 |
Clinical experiences with trandolapril
|
Gaillard, C.A
|
|
1993
|
125 |
5P2 |
p. 1542-1546
5 p.
|
artikel
|
| 4 |
Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia
|
Lind, Lars
|
|
1993
|
125 |
5P2 |
p. 1494-1497
4 p.
|
artikel
|
| 5 |
Hypertension in diabetic nephropathy: Prevention and treatment
|
Ritz, Eberhard
|
|
1993
|
125 |
5P2 |
p. 1514-1519
6 p.
|
artikel
|
| 6 |
Influence of the nonsulfhydryl angiotensin-converting enzyme inhibitor trandolapril on lipid and carbohydrate metabolism related to exercise capacity in healthy subjects
|
Predel, H.-G
|
|
1993
|
125 |
5P2 |
p. 1532-1535
4 p.
|
artikel
|
| 7 |
Introduction: Is hypertension a metabolic disease?
|
Kaplan, Norman M.
|
|
1993
|
125 |
5P2 |
p. 1485-1487
3 p.
|
artikel
|
| 8 |
Pathogenesis and treatment of hypertension associated with diabetes mellitus
|
Weidmann, Peter
|
|
1993
|
125 |
5P2 |
p. 1498-1513
16 p.
|
artikel
|
| 9 |
Pharmacologic profile of trandolapril, a new angiotensin-converting enzyme inhibitor
|
Conen, H
|
|
1993
|
125 |
5P2 |
p. 1525-1531
7 p.
|
artikel
|
| 10 |
Reduction of left ventricular hypertrophy: How beneficial?
|
Messerli, Franz H.
|
|
1993
|
125 |
5P2 |
p. 1520-1524
5 p.
|
artikel
|
Tijdschrift beschrijving